Topics

Eli Lilly remains an attractive proposition through 2019

11:47 EDT 1 May 2019 | Pharmaceutical Technology

Big Pharma experienced a tough year in 2018, with political pricing pressures from regulators and patients forcing companies to reduce...
Read More...

The post Eli Lilly remains an attractive proposition through 2019 appeared first on Pharmaceutical Technology.

Original Article: Eli Lilly remains an attractive proposition through 2019

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly remains an attractive proposition through 2019"

Quick Search